Concepedia

Vernon Rowe

VR

Statistics

Publications

18

Citations

1.7K

H-Index

14

Active since

1974

Affiliations

University of Kansas Medical Center(Current)

Rowe Neurology Institute

The University of Kansas Health System

University of California, San Francisco

Inserm

Vernon Rowe is an author at University of Kansas Medical Center specializing in life sciences, neurology, and neuroscience.

Publications per year

1974–2020

18

Publications

18

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

, , +9

Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial

Denise E. Chou, Marianna Shnayderman Yugrakh, Dana Winegarner et al. · Cephalalgia · 2018 · 173 citations · Full text

, , +15

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Bruce Cree, Gary Cutter, Jerry S. Wolinsky et al. · The Lancet Neurology · 2020 · 104 citations · Full text

, , +9

Solriamfetol for the Treatment of Excessive Sleepiness in OSA

Patrick Strollo, Jan Hedner, Nancy A. Collop et al. · CHEST Journal · 2018 · 81 citations · Full text

, , +17

The Enduring Behavioral Changes in Rats with Experimental Phenylketonuria

Arnold E. Andersen, Vernon Rowe, Gordon Guroff · Proceedings of the National Academy of Sciences · 1974 · 66 citations · Full text

, , +17

1–5 of 18